Services on Demand
Print version ISSN 0042-9686
Bull World Health Organ vol.79 n.4 Genebra Jan. 2001
OBJECTIVE: To assess the impact of the National Immunization Days (NIDs) on measles vaccine coverage in Burkina Faso in 1998.
METHODS: During the week after the campaign, in which measles vaccine was offered to children aged 959 months in six cities regardless of vaccination history, a cluster survey was conducted in Ouagadougou and Bobo Dioulasso, the countrys two largest cities. Interviewers visited the parents of 1267 children aged up to 59 months and examined vaccination cards. We analysed the data using cluster sample methodology for the 1041 children who were aged 959 months.
FINDINGS: A total of 604 (57%) children had received routine measles vaccination prior to the campaign, and 823 (79%) were vaccinated during the NIDs. Among those who had previously had a routine vaccination, 484 (81%) were revaccinated during the NIDs. Among those not previously vaccinated, 339 (78%) received one dose during the NIDs. After the campaign, 943 (91%) children had received at least one dose of measles vaccine. Better socioeconomic status was associated with a higher chance of having been vaccinated routinely, but it was not associated with NID coverage.
CONCLUSION: The mass campaign enabled a substantial increase in measles vaccine coverage to be made because it reached a high proportion of children who were difficult to reach through routine methods.
Keywords: Measles/prevention and control; Measles vaccine/administration and dosage; Immunization programs; Cluster analysis; Burkina Faso (source: MeSH).
Mots clés: Rougeole/prévention et contrôle; Vaccin antimorbilleux/administration et posologie; Programmes de vaccination; Sondage en grappes; Burkina Faso (source: INSERM).
Palabras clave: Sarampión/prevención y control; Vacuna antisarampión/administración y dosificación; Programas de inmunización; Análisis por conglomerados; Burkina Faso (fuente: BIREME).
Supplemental measles vaccination campaigns are a key component of the WHO strategy to eliminate measles. In the Americas most countries have successfully conducted catch-up campaigns to improve vaccine coverage rapidly (1, 2). Burkina Faso, a country with low coverage of routine measles vaccination, conducted two annual rounds of National Immunization Days (NIDs) against poliomyelitis in 1996 and 1997, with coverage exceeding 95% in each round (3). Becauseof the apparent success of the NIDs, additional interventions were included in 1998. In addition to the oral polio vaccine offered to children aged up to 59 months, vitamin A supplementation was offered to those aged 659 months during the first round in November. During the second round in December, measles vaccine was offered in six cities to those aged 959 months regardless of vaccination history.
Only a limited mass measles vaccination strategy was used in 1998 for three main reasons: the feasibility of safe, mass vaccination campaigns requiring injections had not been established; there was a larger number of health care workers trained to administer injections in urban settings; and there was the possibility that vaccinations in urban areas might reduce measles mortality and transmission in rural areas (4).
Mass measles vaccinations have been proposed as a strategy to improve measles control, primarily in areas with high vaccine coverage (5, 6). Previous experience has suggested that mass vaccination campaigns might reach a large proportion of children who had already been vaccinated but not provide substantial benefit to those who had not been vaccinated through routine programmes, and that they might, therefore, have little impact on measles control (7). Whether the mass campaign is extended to cover other areas of Burkina Faso will partly depend on the ability to clarify campaign coverage issues. We conducted a detailed survey in Ouagadougou and Bobo Dioulasso, the two largest cities in Burkina Faso, immediately after the 1998 campaign. Parents were interviewed to collect information on socioeconomic status and to determine whether their children had participated in the immunization days; childrens vaccination cards were also reviewed.
We conducted a cluster survey (8, 9) in two cities within the areas covered by the measles vaccine campaign. Altogether, 121 clusters of 7 children were randomly selected in Ouagadougou (four health districts) and 60 clusters were selected in Bobo Dioulasso (two health districts) using a two-stage sampling method. The 30 sectors of Ouagadougou and the 25 sectors of Bobo Dioulasso were used as secondary stratification levels. The National Institute for Demography provided population estimates for each sector. The location of the first household to be surveyed was randomly identified on a map. Interviewers enrolled children from consecutive households. They were instructed to identify and collect data on all children in each household who were aged up to 59 months. After a household had been surveyed, interviewers moved to the next one, until a total of 7 children aged 059 months could be surveyed for each individual cluster.
The survey took place during the week immediately following the vaccination campaign. Data were collected using closed questions. Interviews were conducted with the principal caregiver of every child. If the caregiver was absent, interviewers registered the name of the child and returned to complete data collection.
We classified children as having been routinely vaccinated if they possessed a vaccination card that recorded one dose of measles vaccine at or after 9 months of age (10). Interviewers used indirect questioning to determine whether a child had received a dose of vaccine during the campaign. First they found out whether the caregiver was aware that the campaign had taken place. If so, they asked if the caregiver remembered the dates on which the campaign had taken place (two rounds separated by a one-month interval). Finally, the caregiver was asked to describe what the child had received (two pink drops signified polio vaccine, red capsules vitamin A, and an injection measles vaccine).
We computed proportions and confidence limits with the CSAMPLE program included in EpiInfo version 6.04c (11). Cities were used as primary strata, the clusters were the primary sampling units, and the size of the population to be vaccinated in each city were the sample weights.
A total of 1267 children aged 059 months grouped in 181 clusters were surveyed. We focused on the 1041 (82%) aged 959 months (Table 1) who were eligible to receive measles vaccine. There were 712 children in Ouagadougou and 329 in Bobo Dioulasso eligible for inclusion. There were vaccination booklets for 80% of children. Altogether, 604 (57%; 95% confidence interval (CI) = 5461%)of children aged 959 months had had a measles vaccination documented before the campaign. Of the children surveyed, 823 (79%; 95% CI = 7683%) received measles vaccine during the immunization days. In total, 943 of the 1041 children (91%; 95% CI = 8893%) had received measles vaccine at least once either routinely or through the campaign.
Children whose principal caregiver had had no education were less likely than others to have been routinely vaccinated against measles prior to the campaign (49% in contrast to 68%; relative risk (RR) 0.71, 95% CI = 0.630.81). Routine coverage increased as the level of the caregivers education increased (Table 2).
The proportion of children who received measles vaccine during the NIDs was similar among children who had documented routine vaccination and those who did not (Fig. 1). Among the 604 who had had a routine vaccination, 484 (81%) were revaccinated during the NIDs. Among the 437 not previously vaccinated, 339 (78%) received one dose during the immunization days. Predictors of a missed routine vaccination were not associated with better coverage during the NIDs. In particular, children whose principal caregiver had had no education were as likely to be vaccinated during the immunization days as other children were (79% vs. 80%; RR 0.99, 95% CI = 0.911.07) (Table 2).
Altogether, 98 (9%) of the children had not received a dose of measles vaccine, either routinely or during the campaigns (Table 3). The risk of not being vaccinated was slightly higher for boys than for girls (RR 1.56, 95% CI = 1.092.24).
The coverage estimates found in the survey were substantially different from those obtained from information on the number of doses administered (Table 4). For the six districts combined, the administrative information suggested that coverage was 107%, while coverage measured by the survey was 79% (95% CI = 7683%). Thus, the administrative method overestimated actual coverage by 35%. In addition, the district with the highest administrative coverage (Bobo Dioulasso sector 22) was also that with the lowest coverage as measured by the survey.
This survey provides useful information for the development of measles control strategies in Burkina Faso. In Ouagadougou and Bobo Dioulasso administering a supplemental dose of measles vaccine, regardless of vaccination history, increased the proportion of children who received at least one dose of measles vaccine from 57% before the campaign to 91%. The campaign also allowed a high proportion of children who are harder to reach routinely to be vaccinated. Finally, findings from this survey suggest that coverage estimates using administrative data on the number of doses given did not adequately identify districts with high and low coverage.
Measles vaccination campaigns have not always achieved satisfactory results. In Manila, Philippines, for example, in a context of routine coverage approaching 90%, the proportion of non-vaccinated children that could be reached by one campaign remained low (7). In other places, campaigns did not reach a large enough proportion of children (12, 13). Data in this report suggest that a carefully planned measles vaccination campaign conducted in a setting of moderate-to-low routine coverage can vaccinate a much larger number of children than routine activities alone, particularly among those who are hard to reach.
Mass vaccination campaigns complement, but are not substitutes for, routine vaccination activities. Campaigns do not allow all the antigens included in the Expanded Programme on Immunization to be administered (10). They also require large numbers of health staff, trained to administer injections, to be mobilized, and they require financial resources. Effective measles control requires a combination of several strategies (1). In developing a national plan for measles control, it is necessary to strengthen disease surveillance, to ensure higher routine coverage with one-dose measles vaccine, and to anticipate that additional mass campaigns might be necessary to compensate for the growth in the numbers of susceptible children over time. Previous experience suggests that after a mass campaign the number of measles cases might increase rapidly within a few years if proper measures are not taken (14).
This report illustrates three different ways of estimating vaccine coverage: reviewing vaccination cards, calculating from data on the number of doses administered, and interviewing caregivers immediately after a campaign. Each method has limitations. In this study, only childrens vaccination cards were used to determine whether a child had been vaccinated routinely, thus there is a possibility that children who had been vaccinated but whose cards did not reflect this may have been misclassified as unvaccinated (15). Assessing vaccine coverage through the number of doses administered is common (16). Although such data are frequently used to make operational decisions, there are concerns about accuracy (17). Data from this survey suggest that the administrative method did not adequately identify districts with low coverage during the campaign. Most of the discrepancies were probably caused by incomplete information on the number of children of the appropriate age and the vaccination of children who fell outside the selected age group. Because the survey relied only on the caregivers statements to determine which, if any, vaccinations had been received during the campaign, there is the potential for misclassification (18). However, maternal reports can provide useful information on vaccine coverage (19). Additional precautions taken for the survey, such as conducting interviews less than 10 days after the campaign and using indirect questioning, are likely to have improved the reliability of the estimates of coverage.
In Ouagadougou and Bobo Dioulasso, poor coverage of measles vaccination could rapidly be compensated for through mass vaccination campaigns because coverage during campaigns is less influenced by socioeconomic factors than routine coverage. In 1999, Burkina Faso developed a national strategic plan for measles control and conducted a thoroughly evaluated national campaign. Follow-up campaigns are planned for 2001 as well as improvements in routine coverage and strengthened surveillance activities to achieve sustainable measles control.
We wish to thank the following people for their support throughout the study: Dr Blaise A. Bamouni, Dr Na-Bintou Bénon, Dr Mete Bonkoungou, Dr Lassouré Compaoré, Dr Charles Ido, Dr Charles Kaboré, Dr Cheik Ouedraogo, Dr Lambert Simporé, Dr Mathias Somé, S.E.M.A. Ludovic Tou, Dr Dieudonné Zongo. Dr Peter Strebel provided valuable assistance in the preparation of the manuscript. UNICEF Burkina Faso provided funding for the survey.
Conflict of interests: none declared.
Vaccination de masse contre la rougeole dans les zones urbaines du Burkina Faso, 1998
OBJECTIF: Evaluer limpact des jourées nationales de vaccination sur la couverture vaccinale antirougeoleuse au Burkina Faso en 1998.
MÉTHODES: La semaine suivant cette campagne, la vaccination antirougeoleuse a été offerte aux enfants de 9 à 59 mois dans six villes, quel que soit leur statut vaccinal antérieur, et une enquête a été réalisée par sondage en grappes à Ouagadougou et Bobo Dioulasso, les deux plus grandes villes du pays. Les enquêteurs ont interrogé les parents de 1267 enfants de moins de 60 mois et ont examiné les carnets de vaccination. Nous avons analysé les données selon la méthode du sondage en grappes pour les 1041 enfants qui étaient âgés de 9 à 59 mois.
RÉSULTATS: Au total, 604 enfants (57 %) avaient reçu une vaccination antirougeoleuse de routine avant la campagne et 823 (79%) ont été vaccinés pendant les journées nationales de vaccination. Parmi les enfants qui étaient déjà vaccinés, 484 (80%) ont été revacciné pendant la campagne, et parmi ceux qui navaient pas encore été vaccinés, 339 (78 %) ont reçu une dose de vaccin. Après la campagne, 943 enfants (91 %) avaient reçu au moins une dose de vaccin antirougeoleux. Un meilleur niveau socio-économique était associé à de plus grandes chances pour lenfant davoir reçu une vaccination de routine, mais nétait pas associé au taux de couverture des journées nationales de vaccination.
CONCLUSION: La campagne de vaccination de masse a permis daugmenter sensiblement la couverture vaccinale car elle a pu toucher une forte proportion denfants difficiles à atteindre par les méthodes classiques.
Vacunación masiva contra el sarampión en zonas urbanas de Burkina Faso, 1998
OBJETIVO: Evaluar la repercusión de los Días Nacionales de Inmunización (DNI) en la cobertura de vacunación antisarampionosa en Burkina Faso en 1998.
MÉTODOS: Durante la semana posterior a la campaña, en la que se ofreció vacunación antisarampionosa a los niños de 9 a 59 meses de seis ciudades con independencia de sus antecedentes de vacunación, se llevó cabo una encuesta por conglomerados en Ouagadougou y Bobo Dioulasso, las principales ciudades del país. Los encuestadores visitaron a los padres de 1267 niños de hasta 59 meses de edad y examinaron sus fichas de vacunación. Analizamos los datos correspondientes a un total de 1041 niños de 9 a 59 meses de edad, empleando métodos adecuados para muestras por conglomerados.
RESULTADOS: En total, 604 niños (57%) habían recibido vacunación antisarampionosa sistemática antes de la campaña, y 823 (79%) fueron vacunados durante los DNI. Entre los que se habían beneficiado anteriormente de la vacunación sistemática, 484 (80%) fueron revacunados durante los DNI. Entre los no vacunados previamente, 339 (78%) recibieron una dosis durante los DNI. Al terminar la campaña, 943 niños (91%) habían recibido como mínimo una dosis de vacuna antisarampionosa. Un mayor estatus socioeconómico se asociaba a una mayor probabilidad de haberse beneficiado de la vacunación sistemática, pero no así de la cobertura de los DNI.
CONCLUSIÓN: La campaña masiva permitió ampliar sustancialmente la cobertura vacunal contra el sarampión, pues se dio alcance a una alta proporción de los niños que difícilmente se benefician de las intervenciones sistemáticas.
1. de Quadros CA et al. Measles elimination in the Americas. Evolving strategies. Journal of the American Medical Association, 1996, 275: 224229. [ Links ]
2. Centers for Disease Control and Prevention. Global measles control and regional elimination 19981999. MMWR Morbidity Mortality Weekly Report, 1999, 48: 11241130. [ Links ]
3. Ministère de la Santé du Burkina Faso. Service de la prévention par les vaccinations. Plan daction pour les JNV 1998 [Action plan for 1998 NIDs]. Ouagadougou, 1998 (unpublished document). [ Links ]
4. Cutts FT et al. Principles of measles control. Bulletin of the World Health Organization, 1991, 69: 17. [ Links ]
5. Azgur Z et al. Pulse mass measles vaccination across age cohorts. Proceedings of the National Academy of Sciences of the United States of America, 1993, 90: 1169811702. [ Links ]
6. Nokes DJ, Swinton J. Vaccination in pulses: a strategy for global eradication of measles and polio? Trends in Microbiology, 1997, 5: 1419. [ Links ]
7. Tangermann R. A measles outbreak after mass immunization campaigns in Manila, Philippines, 1995. World Health Organization Western Pacific Regional Office, 1999 (unpublished document). [ Links ]
8. Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bulletin of the World Health Organization, 1982, 60: 253260. [ Links ]
9. Lemeshow S, Robinson D. Surveys to measure programme coverage and impact: a review of the methodology used by the Expanded Programme on Immunization. World Health Statistics Quarterly, 1985, 38: 6575. [ Links ]
10. World Health Organization. Immunization in practice. Modules 111. Geneva, World Health Organization, 1998 (unpublished document WHO/EPI/TRAM/98.0111). [ Links ]
11. Dean AG et al. EpiInfo, version 6: a word processing, database, and statistics program for public health on IBM compatible microcomputers. Atlanta, GA, Centers for Disease Control and Prevention, 1996. [ Links ]
12. Kearney M et al. Evaluation of a mass measles immunisation campaign in a rapidly growing peri-urban area. South African Medical Journal, 1989, 76: 157159. [ Links ]
13. Berry DJ, Yach D, Hennink MHJ. An evaluation of the national measles vaccination campaign in the new shanty areas of Khayelitsha. South African Medical Journal, 1991, 79: 433436. [ Links ]
14. Abdool Karim SS et al. Unsustainability of a measles immunisation campaignrise in measles incidence within 2 years of the campaign. South African Medical Journal, 1993, 83: 322323. [ Links ]
15. Gareaballah ET, Loevinsohn BP. The accuracy of mothers reports about their childrens vaccination status. Bulletin of the World Health Organization, 1989, 67: 669674. [ Links ]
16. Cutts FT, Olivé JM. Vaccination programs in developing countries. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia, WB Saunders, 1999: 10471073. [ Links ]
17. Borgdorff MW, Walker GJ. Estimating vaccination coverage: routine information or sample survey? Journal of Tropical Medicine and Hygiene, 1988, 91: 3542. [ Links ]
18. Valadez JJ, Weld LH. Maternal error of child vaccination status in developing nation. American Journal of Public Health, 1992, 82: 120122. [ Links ]
19. Goldman N, Pebley AR. Health cards, maternal reports and the measurement of immunization coverage: the example of Guatemala. Social Science and Medicine, 1994, 38: 10751089. [ Links ]
1 Medical Officer, WHO Representatives Office, Ouagadougou, Burkina Faso. Correspondence should be addressed to this author, whose current address is Centers for Disease Control and Prevention, 1600 Clifton Road MS-E05, Atlanta GA 30333, USA (email firstname.lastname@example.org).
2 Medical Officer, Regional Health Directorate of Ouagadougou, Burkina Faso.
3 Medical Officer, Regional Health Directorate of Bobo Dioulasso, Burkina Faso.
4 EPI coordinator, Regional Health Directorate of Bobo Dioulasso, Burkina Faso.
5 Former Head, Vaccine and Prevention, Directorate of Preventive Medicine, Ministry of Health, Burkina Faso.
6 Director, Regional Health Directorate of Ouagadougou, Burkina Faso.
Ref. No. 99-0402